Celestica (CLS) director receives 237 director share units in Form 4 filing
Rhea-AI Filing Summary
Celestica Inc. reported a routine insider equity award for one of its directors. On 12/31/2025, the director received 237 director share units, which are a type of derivative security tied to Celestica common shares. These units were granted at a price of $0 and increase the director’s holdings to 992 derivative securities after the transaction.
Each director share unit represents a contingent right to receive one Celestica common share, or an equivalent cash amount, at the company’s discretion when the holder stops serving as a director, consultant, or other service provider. The filing indicates the director’s ownership is held directly and reflects standard equity-based compensation rather than an open‑market purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Director Share Units | 237 | $0.00 | -- |
Footnotes (1)
- [object Object]
FAQ
What insider transaction did Celestica Inc (CLS) disclose in this Form 4?
Celestica disclosed that a director received 237 director share units on 12/31/2025, increasing the director’s holdings of derivative securities to 992 units held directly.
Was the Celestica (CLS) director equity transaction a purchase or a grant?
The Form 4 shows a grant of director share units with a price of $0, indicating it is equity compensation rather than an open‑market purchase or sale.
How many Celestica (CLS) derivative securities does the director own after this transaction?
Following the grant of 237 director share units, the Form 4 reports that the director beneficially owns 992 derivative securities, held directly.
Does this Celestica (CLS) Form 4 indicate use of a Rule 10b5-1 trading plan?
The form includes a checkbox for indicating transactions under a Rule 10b5-1(c) plan, but the excerpt does not show this box marked for the reported director share unit grant.